SCHEMBL24656023

SCHEMBL24656023

Cc1[nH]nnc1-c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.40
▸ HTR1D P28221 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ HTR1E P28566 1/20 0.40
▸ HTR7 P34969 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ PTGS2 P35354 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ ALPL P05186 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ AXL P30530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20915560 0.80 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2ALPLNPC1RAB9A
SCHEMBL2387037 0.79 AKT2 (0.44) PTGS2ALDH1A1SMN1; SMN2ALPLMAPK14
SCHEMBL20915705 0.73 XDH (0.49) PTGS2ALDH1A1SMN1; SMN2KDM4EMEN1
SCHEMBL14307558 0.72 MAPK14 (0.40) PTGS2MAPK14NPC1RAB9AAXL
SCHEMBL25210468 0.72 ALDH1A1 (0.47) HTR1AHTR1DHTR2AHTR2CHTR1E
SCHEMBL23294286 0.72 MAP2K4 (0.38) ALPLMAPK1RAB9A
SCHEMBL17969086 0.72 ERBB2 (0.49) HTR1AHTR1DHTR2AHTR2CHTR1E
SCHEMBL25220966 0.71 MAPK14 (0.57) ALDH1A1MAPK14MAPK1KDM4ETSHR
SCHEMBL14705874 0.71 HAO1 (0.49) ALDH1A1SMN1; SMN2ALPLMAPK14MAPK1
SCHEMBL18006079 0.71 ERBB2 (0.47) ALDH1A1SMN1; SMN2ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022234271-A1 HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2022-11-10 — — WO disclosed
Send feedback